Euro-Med Laboratories Philippines (PHS:EURO) Payments of Debt: ₱-3,443 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PHS:EURO Euro-Med Laboratories Philippines Inc PHS:EURO
83 GF Score
Price ₱1.10
GF Value ₱1.03
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Euro-Med Laboratories Philippines Payments of Debt?

Euro-Med Laboratories Philippines PHS:EURO 83 Payments of Debt is ₱-3,443 Mil as of Mar. 2026. GuruFocus rates PHS:EURO with a GF Score™ of 83/100 and a GF Value™ of ₱1.03 (Fairly Valued). The stock has 7 warning signs investors should review.

Euro-Med Laboratories Philippines's Payments of Debt for the three months ended in Mar. 2026 was ₱-460 Mil.

Euro-Med Laboratories Philippines's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was ₱-3,443 Mil.

Euro-Med Laboratories Philippines Payments of Debt Related Terms

Euro-Med Laboratories Philippines Payments of Debt Historical Data

* Premium members only.

The historical data trend for Euro-Med Laboratories Philippines's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euro-Med Laboratories Philippines Payments of Debt Chart

Euro-Med Laboratories Philippines Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,671.87 -2,248.50 -3,377.97 -3,135.33 -3,419.05

Euro-Med Laboratories Philippines Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,090.49 -1,157.27 -942.34 -883.97 -459.54
PHS:EURO
83GF Score
Euro-Med Laboratories Philippines Inc PHS:EURO
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Euro-Med Laboratories Philippines Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₱-3,443 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of ₱-3,443 Mil mean?
Euro-Med Laboratories Philippines (PHS:EURO) has a Payments of Debt of ₱-3,443 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Euro-Med Laboratories Philippines and its competitors.
Is Euro-Med Laboratories Philippines' Payments of Debt too high?
Euro-Med Laboratories Philippines' current Payments of Debt is ₱-3,443 Mil. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' Payments of Debt compare to ZTS and UTHR?
Euro-Med Laboratories Philippines' Payments of Debt of ₱-3,443 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Drug Manufacturers company?
A good Payments of Debt depends on the Drug Manufacturers industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Euro-Med Laboratories Philippines and its competitors. Euro-Med Laboratories Philippines's current Payments of Debt is ₱-3,443 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.03, compared to a current price of ₱1.10 — trading 6.8% above its estimated fair value. The current Payments of Debt is ₱-3,443 Mil. Euro-Med Laboratories Philippines' overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current Payments of Debt is ₱-3,443 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?

Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued. The current stock price of ₱1.10 is trading 6.8% above its estimated GF Value™ of ₱1.03. GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.

Key valuation signals for PHS:EURO:

  • Payments of Debt: ₱-3,443 Mil
  • GF Value™: ₱1.03 vs. price of ₱1.10 (6.8% above fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Euro-Med Laboratories Philippines Business Description

Address San Marcelino Street, United Nations Avenue corner, PPL Building, 2nd floor, Manila, PHL, 1000
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
83GF Score

Get the complete analysis for PHS:EURO

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₱1.10
Price
₱1.03
GF Value